【Blueberry Therapeutics-Product BB2603】UK-Based Nanomedicine Firm Set Plans to Initiate a Large Phase II Efficacy Study in 2019

25^thSep 2019- Helius Medical Technologies, Inc. issued an announcement, which is summarized as follows：

Helius Medical Technologies, Inc. and HealthTech Connex, announce the grand opening of Apollo Physical Therapy Centre (“Apollo”), Canada’s fifth clinic to offer the groundbreaking PoNS Treatment? featuring the non-invasive PoNS? (Portable Neuromodulation Stimulator) device.

The 14-week PoNS Treatment program provides innovative therapeutic treatment designed to help clients improve chronic balance and gait deficits associated with mild-to-moderate traumatic brain injury (mmTBI), including concussion, in a non-invasive way. With the PoNS Treatment, Apollo utilizes physical therapy and HealthTech Connex’s NeuroCatch? Platform, which is also authorized for sale in Canada.

The original website link：

https://heliusmedical.com/index.php/newsroom/news-release/2019/300-